Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China flag China · Delayed Price · Currency is CNY
22.85
-0.60 (-2.56%)
At close: May 12, 2026

SHE:003020 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
4,4604,9223,4564,4953,9564,248
Market Cap Growth
25.57%42.42%-23.11%13.63%-6.89%33.39%
Enterprise Value
4,1874,6513,2304,1803,3103,631
Last Close Price
23.4525.8817.5022.3319.5120.95
PE Ratio
27.2529.8021.5219.8318.9024.67
Forward PE
-24.4715.8317.14--
PS Ratio
2.883.172.282.371.531.87
PB Ratio
2.242.521.812.402.673.26
P/TBV Ratio
2.663.012.223.002.833.50
P/FCF Ratio
35.1252.1280.29732.38--
P/OCF Ratio
18.5423.1217.5022.0719.7226.77
EV/Sales Ratio
2.702.992.132.201.281.60
EV/EBITDA Ratio
15.9118.5414.2417.3114.9918.17
EV/EBIT Ratio
25.1927.9721.2620.3116.9921.07
EV/FCF Ratio
32.9749.2675.04681.13--
Debt / Equity Ratio
0.040.030.060.050.010.02
Debt / EBITDA Ratio
0.270.240.500.350.060.12
Debt / FCF Ratio
0.560.682.7614.41--
Net Debt / Equity Ratio
-0.21-0.20-0.20-0.25-0.42-0.48
Net Debt / EBITDA Ratio
-1.64-1.55-1.72-1.97-2.85-3.15
Net Debt / FCF Ratio
-3.27-4.13-9.05-77.5613.7422.30
Asset Turnover
0.590.600.600.831.361.42
Inventory Turnover
2.342.592.073.085.887.16
Quick Ratio
1.811.821.601.621.612.98
Current Ratio
2.282.262.042.122.333.72
Return on Equity (ROE)
8.10%8.46%8.05%13.95%15.03%13.90%
Return on Assets (ROA)
3.96%4.02%3.75%5.59%6.41%6.71%
Return on Invested Capital (ROIC)
9.46%9.70%9.23%16.64%22.29%27.55%
Return on Capital Employed (ROCE)
7.90%8.10%7.60%10.60%13.00%12.80%
Earnings Yield
3.64%3.36%4.65%5.04%5.29%4.05%
FCF Yield
2.85%1.92%1.25%0.14%-1.16%-0.66%
Dividend Yield
2.13%-2.86%1.87%1.64%1.65%
Payout Ratio
79.09%100.59%50.40%27.03%30.99%26.90%
Buyback Yield / Dilution
1.59%0.68%0.47%-1.75%-0.49%-33.01%
Total Shareholder Return
3.74%0.68%3.33%0.12%1.15%-31.37%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.